Specific Central Nervous System Medications Are Associated with Temporomandibular Joint Symptoms

Table 2

Comparison of the type of SSRI medication by the presence of TMD symptoms. The results show that Celexa is the SSRI that is significantly different compared to the rest.

	TMD diagnosis		Total
	No discomfort	Positive for discomfort
Type of SSRI
None
Count	80	42	122
Expected count	72.8	49.2	122.0
% within type of SSRI	65.6%	34.4%	100.0%
Adjusted residual	1.5	−1.5
Celexa
Count	30	35	65
Expected count	38.8	26.2	65.0
% within type of SSRI	46.2%	53.8%	100.0%
Adjusted residual		2.4
Lexapro
Count	40	30	70
Expected count	41.8	28.2	70.0
% within type of SSRI	57.1%	42.9%	100.0%
Adjusted residual	−.5	.5
Prozac
Count	58	27	85
Expected count	50.7	34.3	85.0
% within type of SSRI	68.2%	31.8%	100.0%
Adjusted residual	1.8	−1.8
Luvox
Count	8	4	12
Expected count	7.2	4.8	12.0
% within type of SSRI	66.7%	33.3%	100.0%
Adjusted residual	.5	−.5
Paxil
Count	17	12	29
Expected count	17.3	11.7	29.0
% within type of SSRI	58.6%	41.4%	100.0%
Adjusted residual	−.1	.1
Zoloft
Count	41	34	75
Expected count	44.8	30.2	75.0
% within type of SSRI	54.7%	45.3%	100.0%
Adjusted residual	−1.0	1.0
Lexapro and Zoloft
Count	2	3	5
Expected count	3.0	2.0	5.0
% within type of SSRI	40.0%	60.0%	100.0%
Adjusted residual	−.9	.9
Lexapro and Prozac
Count	2	0	2
Expected count	1.2	.8	2.0
% within type of SSRI	100.0%	0.0%	100.0%
Adjusted residual	1.2	−1.2
Lexapro and Paxil
Count	0	2	2
Expected count	1.2	.8	2.0
% within type of SSRI	0.0%	100.0%	100.0%
Adjusted residual	−1.7	1.7
Celexa and Zoloft
Count	2	0	2
Expected count	1.2	.8	2.0
% within type of SSRI	100.0%	0.0%	100.0%
Adjusted residual	1.2	−1.2
Total
Count	280	189	469
Expected count	280.0	189.0	469.0
% within type of SSRI	59.7%	40.3%	100.0%

Bold highlights the highest adjusted residual.